주요서비스 바로가기
본문 바로가기
매체정보 바로가기
로그인 바로가기
기사검색 바로가기
전체서비스 바로가기
Updated : Friday, March 29, 2024, 09:58
Home
Login
Sign in
한국어
National
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
Macro-Economics
Trade
Foreign Exchanges
Industries
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
Company & Stock Tracking
Market Trend & Outlook
Finance
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
Science
New Tech
Blockchain
ESG
Environment
Social
Governance
Event
Exhibitions
Conferences
People
K-Culture
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
Editorials
Contributions
Who's Who
기사검색
검색
All articles
List
Subject Type
Summary Type
Photo Type
Samsung Bioepis Considering Acquisition of Biogen’s Biosimilars Business in US
Jasmine Choi
2023.08.02 18:18
Biopharmaceuticals Added to National Strategic Technology List, Eligible for Up to 35% Tax Deduction
Kim Eun-jin
2023.07.28 11:08
US Truxima price falls more than expected
Pyeongkuk Park
2023.07.17 18:39
Samsung Bioepis, Humira Biosimilar Listed by US PBM Prime
Jasmine Choi
2023.07.14 10:42
June data confirms favorable XCopri prescription growth
Pyeongkuk Park
2023.07.10 17:40
Samsung Bioepis, Celltrion to Target US$20 Billion US Humira Similar Market
Jung Suk-yee
2023.07.03 09:38
Samsung Biologics, Pfizer Announce Strategic Partnership
Jasmine Choi
2023.06.08 18:14
Celltrion Starts Development of Oral Form of Humira Biosimilar CT-P17
Jasmine Choi
2023.06.05 19:58
Taking another good look
Jaewon Jeong
2023.05.23 10:47
Samsung Biologics Faced with Patent Lawsuit from Regeneron in US
Yoon Young-sil
2023.05.19 11:59
Samsung Chairman Talks Promotion with Pharma Giants, Bio-venture Startups in US
Jung Min-hee
2023.05.08 10:49
Entering profit margin normalization phase on solid US prescriptions and one-off cost relief
Pyeongkuk Park
2023.04.10 17:42
처음
이전
이전
1
2
3
4
5
6
7
8
9
10
다음
다음
끝
위로
모바일버전
All articles
National
전체
Foreign Affairs
Central & Regional Affairs
Social Issues
Economics
전체
Macro-Economics
Trade
Foreign Exchanges
Industries
전체
ICT
Automobiles
Heavy & Chemical
Defence
Entertainment
Energy
Construction
Healthcare & Bio
Consumer
Services
Stock Market
전체
Company & Stock Tracking
Market Trend & Outlook
Finance
전체
Capital Market
Crypto
Banking
Insurances
Startups
Science/Tech
전체
Science
New Tech
Blockchain
ESG
전체
Environment
Social
Governance
Event
전체
Exhibitions
Conferences
People
K-Culture
전체
Cinema/Drama
K-pop
Food
Lifestyle
Arts/Culture
Opinion
전체
Editorials
Contributions
Who's Who
전체메뉴닫기